CAMBRIDGE, Mass., Jan. 31, 2019 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the
field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the company will host a conference
call and live webcast on Thursday, February 14, 2019 at 8:00 a.m. ET to report its fourth quarter and full year 2018 financial
results and other business highlights.
A live webcast can be accessed under "Events & Presentations" in the Investors section of the company's website at
www.agios.com. The conference call can be accessed by dialing 1-877-377-7098 (domestic) or 1-631-291-4547 (international) and
referring to conference ID 9886713. The webcast will be archived and made available for replay on the company's website beginning
approximately two hours after the event.
About Agios
Agios is focused on discovering and developing novel investigational medicines to treat cancer and rare genetic diseases through
scientific leadership in the field of cellular metabolism. In addition to an active research and discovery pipeline across both
therapeutic areas, Agios has two approved oncology precision medicines and multiple first-in-class investigational therapies in
clinical and/or preclinical development. All Agios programs focus on genetically identified patient populations, leveraging our
knowledge of metabolism, biology and genomics. For more information, please visit the company's website at www.agios.com.
Contacts
Agios Investors Contact:
Kendra Adams, 617-844-6407
Senior Director, Investor & Public Relations
Kendra.Adams@agios.com
Agios Media Contact:
Holly Manning, 617-844-6630
Associate Director, Corporate Communications
Holly.Manning@agios.com
